BACHURSKI, Patryk, CHMIEL, Gabriela, KALINOWSKI, Paweł, MIĘDLAR, Maja, MUDA, Martyna, PACEK, Szymon, PIERZGA, Elisabetta, WIŚNIEWSKI, Karol, WITKOWSKI, Paweł and ZARAŃSKI, Bartosz. Optimal First-Line Use of Pembrolizumab in Metastatic Driver-Negative NSCLC: Monotherapy Versus Chemo-Immunotherapy (Evidence 2022–2025). Quality in Sport. Online. 31 January 2026. Vol. 51, p. 68252. [Accessed 1 February 2026]. DOI 10.12775/QS.2026.51.68252.